Cigarette smoking, particularly when associated with chronic pulmonary disease, increases the risk of respiratory tract infection. Thus, we elevated the uptake of antibiotics by alveolar macrophages (AM) obtained by bronchoalveolar lavage from persons who smoke and have associated pulmonary abnormalities, circumstances which adversely affect certain macrophage functions. The entry of radiolabeled drugs into AM was determined by a velocity-gradient centrifugation technique, and uptake was expressed as the ratio of cellular to extracellular antibiotic concentration (C/E). Cefamandole and penicillin G were taken up poorly by the AM obtained from smokers (C/E c 1). Cellular levels of isoniazid, gentamicin, and tetracycline were similar to their extracellular concentrations. The lipid-soluble drugs lincomycin, chloramphenicol, and rifampin were concentrated severalfold by the AM from smokers (C/E = 3 to 11). Ethambutol also entered macrophages readily (C/E = 11). Erythromycin and clindamycin were massively concentrated by the AM from smokers (C/E = 23 to 56). The AM of smokers accumulated a lipid-soluble antibiotic (rifampin) and actively transported agents (erythromycin propionate, clindamycin) more avidly than did the AM of nonsmoker$. Augmented uptake of these antibiotics by the AM of smokers may be related to structural and functional alterations induced by smoking.
People who smoke cigarettes, especially those with associated chronic obstructive pulmonary disease, are more susceptible to respiratory infections than those who do not smoke (3, 15) . It is possible that smoking and its associated respiratory tract abnormalities may predispose smokers to pulmonary infection in part by interfering with the function of pulmonary alveolar macrophages (AM), the predominant phagocytes in the lungs (5, 10, 13) .
The usefulness of antibiotics in treating certain pulmonary infections, particularly those due to facultative intracellular organisms, may depend to some extent upon the ability of the drug to enter phagocytes and kill viable intracellular organisms. With this in mind, we recently studied the uptake of 12 antibiotics by AM from healthy, nonsmoking volunteers (6) volume of 250 ml. When the location of the pulmonary pathology (mass lesion, bleeding, etc.) could be demonstrated, lavage was performed in an uninvolved lung segment. Total and differential cell counts and viability determinations were performed as previously described (1, 16 (6, 7, 14 exclusion. Uptake of antibiotics by AM. Cefamandole and penicillin G were taken up poorly by the AM from smokers (C/E c 1) (Table 1) . Gentamicin, tetracycline, and isoniazid achieved cellular levels which were similar to or slightly greater than their extracellular concentrations. The more lipid-soluble drugs lincomycin, chloramphenicol, and rifampin were concentrated severalfold by the AM of smokers (C/E = 3 to 11). Ethambutol, a drug which is accumulated by complex mechanisms in other phagocytes (14, 17) , also readily entered the AM of smokers (C/E = 11).
The most striking results occurred in studies with erythromycin, erythromycin propionate, and clindamycin, which were massively concentrated by AM (C/E = 23, 32, and 56, respectively). In previous studies, we have demonstrated that these antibiotics enter phagocytes by means of active transport mechanisms (6, 7, 14, 17) . With clindamycin, transport is by means of the cell membrane nucleoside system (7, 19) .
Antibiotic uptake studies with AM of healthy, nonsmoking volunteers (6) were performed in our laboratory during the same time period as the experiments with the AM of smokers. Each of the antibiotics entered the AM of smokers at least as well as it did the cells of the nonsmokers. Although the uptake of most of the antibiotics was the same in both cell populations, the AM of smokers accumulated several antibiotics to a greater extent than did the AM of nonsmokers. Thus, the actively transported agents clindamycin and erythromycin propionate reached higher levels in the AM of smokers than in the AM of nonsmokers (Fig.  1) . The erythromycin base was also concentrated more avidly by the AM of smokers, but only two experiments were performed with cells from nonsmokers, precluding a meaningful comparison of the groups. Rifampin, a highly lipid-soluble drug which enters phagocytes by simple solubility partition (14, 17) , also reached a significantly higher level in the cells of smokers (Fig. 1) .
DISCUSSION
Cigarette smokers, especially those with associated chronic obstructive pulmonary disease, are at increased risk of respiratory tract infection (3, 15, 20) . Since AM are the major phagocytic cells in the lung, their function is of particular importance in protection against and recovery from bacterial infection in the lower respiratory tract (4) . Relationships among AM, bacteria, and antibiotics might be crucial in defense against those bacterial infections which smokers may be responsible for enhanced uptake of rifampin (a lipid-soluble drug) by these cells. Previous demonstrations of stimulated metabolic pathways and altered membrane function in the AM of smokers are compatible with our findings of enhanced uptake of erythromycin and clindamycin, antibiotics which enter phagocytes by active cell membrane transport systems. Our observations demonstrating satisfactory antibiotic uptake by the AM of smokers are encouraging with respect to therapy of infection in patients with underlying lung disease. However, it is now imperative to actually determine the effects of these drugs on organisms which persist after being ingested by the AM of such patients. In the present study, we evaluated the uptake of antimicrobial agents by AM from smokers with underlying lung disease and compared these results with those of our studies in normal individuals (6) . All tested antibiotics entered the AM of the patients at least as well as they entered the AM of normal nonsmokers. Thus, as in studies with the AM of nonsmokers, P-lactam antibiotics entered the AM of smokers poorly, and both gentamicin and isoniazid achieved cellular concentrations in the AM of smokers similar to those in the extracellular fluid. Lipid-soluble antibiotics (e.g., rifampin) and actively transported agents (clindamycin, erythromycin antibiotics) were efficiently concentrated (several-to manyfold) by the AM of smokers. It was of interest that the AM of smokers concentrated these antibiotics more avidly than did the AM of nonsmokers. Thus, rifampin, clindamycin, and erythromycin propionate reached higher levels in the AM of smokers.
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It is probable that cigarette smoking per se is responsible for the augmented accumulation of lipid-soluble and actively transported antibiotics by the AM of smokers. There are several pieces of evidence which favor this possibility. First, no single, unifying respiratory tract disease was present in all of the smokers. Second, in preliminary studies with AM of healthy, young cigarette smokers, we found that antibiotic uptake values were similar to those reported in the present study. Third, reported structural and functional alterations of AM from healthy smokers (2, 8-13, 16, 18, 21, 22) could account for the augmented accumulation of specific antibiotics. Thus, the increased lipid content of the AM of
